Lemonade Inc
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
LMND$39.28-1.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets at (Unaudited) and
CONDENSED CONSOLIDATED BALANCE SHEETS
($ in millions, except share and per share amounts)
| As of | ||
|---|---|---|
| March 31, | December 31, | |
| 2025 | 2024 | |
| (Unaudited) | ||
| Assets | ||
| Investments | ||
| Fixed maturities available-for-sale, at fair value (amortized cost: $654.1 million and $607.1 million as of March 31, 2025 and December 31, 2024, respectively) | $655.6 | $607.4 |
| Short-term investments (cost: $20.5 million and $27.5 million as of March 31, 2025 and December 31, 2024, respectively) | 20.5 | 27.5 |
| Total investments | 676.1 | 634.9 |
| Cash, cash equivalents and restricted cash | 319.7 | 385.7 |
| Premium receivable, net of allowance for credit losses of $2.8 million and $2.8 million as of March 31, 2025 and December 31, 2024, respectively | 317.8 | 301.2 |
| Reinsurance recoverable | 182.3 | 170.4 |
| Prepaid reinsurance premium | 263.5 | 253.6 |
| Deferred acquisition costs | 11.4 | 12.2 |
| Property and equipment, net | 16.2 | 16.1 |
| Intangible assets | 11.2 | 13.6 |
| Goodwill | 19.0 | 19.0 |
| Other assets | 39.4 | 42.4 |
| Total assets | $1,856.6 | $1,849.1 |
| Liabilities and Stockholders' Equity | ||
| Unpaid loss and loss adjustment expense | $307.3 | $298.1 |
| Unearned premium | 476.2 | 455.0 |
| Trade payables | 3.4 | 4.5 |
| Funds held for reinsurance treaties | 225.1 | 219.6 |
| Deferred ceding commission | 61.0 | 65.6 |
| Ceded premium payable | 26.2 | 23.8 |
| Borrowings under financing agreement | 101.9 | 83.4 |
| Other liabilities and accrued expenses | 110.0 | 105.7 |
| Total liabilities | 1,311.1 | 1,255.7 |
| Commitments and Contingencies (Note 15) | ||
| Stockholders' equity | ||
| Common stock, $0.00001 par value, 200,000,000 shares authorized; 73,212,871 and 72,720,866 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | — | — |
| Additional paid-in capital | 1,910.1 | 1,898.3 |
| Accumulated deficit | (1,361.2) | (1,298.8) |
| Accumulated other comprehensive loss | (3.4) | (6.1) |
| Total stockholders' equity | 545.5 | 593.4 |
| Total liabilities and stockholders' equity | $1,856.6 | $1,849.1 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.